Ethosuximide is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Ethosuximide.
Product ID | 0093-9660_66f84cc7-8014-417d-af1d-935e85223b7f |
NDC | 0093-9660 |
Product Type | Human Prescription Drug |
Proprietary Name | Ethosuximide |
Generic Name | Ethosuximide |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 1994-07-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA081306 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | ETHOSUXIMIDE |
Active Ingredient Strength | 250 mg/5mL |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1994-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA081306 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1994-07-01 |
Marketing End Date | 2019-10-31 |
Ingredient | Strength |
---|---|
ETHOSUXIMIDE | 250 mg/5mL |
SPL SET ID: | b2f96a67-75a5-4c9e-a706-b88114d15a17 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0093-9660 | Ethosuximide | Ethosuximide |
0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE |
23155-532 | ETHOSUXIMIDE | ETHOSUXIMIDE |
42806-711 | Ethosuximide | Ethosuximide |
46672-641 | ethosuximide | ethosuximide |
59762-2250 | Ethosuximide | Ethosuximide |
59762-2350 | Ethosuximide | Ethosuximide |
61748-024 | Ethosuximide | Ethosuximide |
61748-025 | Ethosuximide | Ethosuximide |
63629-8005 | Ethosuximide | Ethosuximide |
64380-878 | ETHOSUXIMIDE | ETHOSUXIMIDE |
68382-443 | ethosuximide | ethosuximide |
69387-108 | Ethosuximide | Ethosuximide |
69452-152 | Ethosuximide | Ethosuximide |
71335-1763 | ETHOSUXIMIDE | ETHOSUXIMIDE |
0071-0237 | Zarontin | Ethosuximide |
0071-2418 | Zarontin | Ethosuximide |